Cargando…
Preventing false discovery of heterogeneous treatment effect subgroups in randomized trials
BACKGROUND: Heterogeneous treatment effects (HTEs), or systematic differences in treatment effectiveness among participants with different observable features, may be important when applying trial results to clinical practice. Current methods suffer from a potential for false detection of HTEs due t...
Autores principales: | Rigdon, Joseph, Baiocchi, Michael, Basu, Sanjay |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6048878/ https://www.ncbi.nlm.nih.gov/pubmed/30012181 http://dx.doi.org/10.1186/s13063-018-2774-5 |
Ejemplares similares
-
Grouped False-Discovery Rate for Removing the Gene-Set-Level Bias of RNA-seq
por: Yang, Tae Young, et al.
Publicado: (2013) -
A unified approach to false discovery rate estimation
por: Strimmer, Korbinian
Publicado: (2008) -
False discovery rate control in two-stage designs
por: Zehetmayer, Sonja, et al.
Publicado: (2012) -
Importance of presenting the variability of the false discovery rate control
por: Lin, Yi-Ting, et al.
Publicado: (2015) -
Using controls to limit false discovery in the era of big data
por: Parks, Matthew M., et al.
Publicado: (2018)